CD19 and bronchiectasis: Amongst individuals with CVID, and more broadly amongst those with primary antibody deficiency, serum sBCMA concentrations, but not serum IgA, IgM concentrations or peripheral blood CD19+ B cell count, showed relatively limited potential to discriminate between individuals with and without bronchiectasis (Fig. 2a and b).